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Background: Postoperative pancreatic fistula (POPF) is the most common significant complication after
distal pancreatectomy (DP) and results in substantial morbidity. Many different methods are available to
divide the pancreatic parenchyma and achieve stump closure, but demonstrating an improvement in the
incidence of POPF has been difficult.
Methods: A single-institution, retrospective review was conducted to evaluate all hand-assisted laparo-
scopic DP performed from October 2008 to July 2011 utilizing saline-coupled radiofrequency ablation
(RFA) as the exclusive method of achieving division of the pancreatic parenchyma and closure of the
proximal pancreatic remnant. All significant complications within the perioperative period were noted.
Results: Thirty-four patients met the criteria for inclusion in the study. One patient was lost to follow-up
and thus excluded. Three patients (9.1%) demonstrated a POPF; two were treated with prolonged
placement of the intraoperative drain (grade A: 6.1%) and the third was treated with endoscopic
cystogastrostomy (grade C: 3.0%). One other significant complication (3.0%) of a perforated gastric ulcer
that required partial gastrectomy occurred.
Conclusions: The use of saline-coupled RFA alone for pancreatic parenchymal division and closure
after DP is safe and effective. This study found an overall significant complication rate of 6.1%, and a rate
of clinically significant POPF of 3.0%.
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Introduction
Distal pancreatectomy (DP) is the procedure of choice for resec-
table benign and malignant lesions of the pancreatic body and
tail.1,2 Serious complications of DP include pancreatic fistula
and abscess. Postoperative pancreatic fistula (POPF) is the most
common significant complication after DP and results in substan-
tial morbidity. Currently, reported incidences of POPF after DP
range widely from 5% to 33%.1–5 Significant fistula (grades B and
C) as defined according to the International Study Group on
Pancreatic Fistula (ISGPF) occurs in 9% to 16% of reported
cases.1,3–7 Unfortunately, this rate has not changed appreciably in
over a decade, during which time overall mortality from DP has
dropped significantly.1,8,9
Although not completely understood, a host of factors, both
technical and patient-related, are thought to contribute to an
increased risk for the development of POPF. Patient-specific risk
factors for POPF include obesity, male gender and tobacco use.2
The consistency of the pancreatic parenchyma as a contributing
factor is debatable: some authors have found that a soft, normal
pancreas is more likely to experience complications than a firm,
fibrotic parenchyma that will hold sutures or staples more
effectively.1,7,9–12
Technical factors associated with the development of a POPF
include the method utilized for pancreatic transection and any
subsequent stump treatment. Although this association is direct
and logical, published reports vary widely regarding the impact of
specific techniques utilized during DP on rates of POPF. To date,
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large series have been unable to clearly identify a superior method
for either parenchymal division or stump treatment. Although
many different methods are available to divide the pancreatic
parenchyma, the most commonly used are transection with
cautery or stapler. Stapled transection is variably performed with
or without a bio-absorbable staple line reinforcement. Performing
another major procedure concomitantly with the DP has also
been shown to predispose to the development of a POPF.2
Parenchymal transection is commonly followed by treatment of
the pancreatic stump. This is performed to promote sealing of the
parenchyma in order to minimize the incidence of leak and sub-
sequent POPF.Options are diverse and include cautery, fibrin glue
and omental patches. Currently, the most common method is
suture reinforcement, but no data exist to define an optimal
method. For example, some reports have found that oversewing
the main pancreatic duct after stapled transection of the pancreas
results in a reduced incidence of POPF,13 whereas others have
found no such association.5
Although the various methods available for pancreatic paren-
chymal division and closure have been compared many times,
demonstrating a superior method that effectively reduces the inci-
dence of POPF has been elusive. The purpose of this study was to
review the safety and effectiveness of saline-coupled radiofre-
quency ablation (RFA) for both division and remnant treatment
during DP. Interest in exploring an alternative technique stemmed
from the persistently high POPF rate seen with the use of current
techniques and equipment. Saline-coupled RFA was adopted
because it has been shown to be effective in a porcine model14 and
has demonstrated promising early results in hepatic and renal
resections.15–17
Materials and methods
A single-institution, retrospective review was conducted from
October 2008 to July 2011 to evaluate all hand-assisted, laparo-
scopic DPs utilizing saline-coupled RFA (EndoSH 2.0™; Salient
Surgical Technologies, Inc., Portsmouth, NH, USA) as the exclu-
sive method for achieving division of the pancreatic parenchyma
and closure of the proximal pancreatic remnant. After routine
exposure of the pancreas, it is inspected to ensure resectability.
A line of transection is identified, utilizing intraoperative ultra-
sound when necessary, that will allow a margin of at least 1–2 cm
to be attempted. Isolation of the splenic vessels is followed by
stapled transection in cases of splenectomy, and by complete dis-
section and exclusion from the distal pancreas in cases of splenic
preservation. Control of the pancreas body is maintained by hand
assistance during transection using an EndoSH™ hook. Pancre-
atic tissue is lifted and cauterized while saline-coupling is main-
tained to ensure the complete sealing of the parenchyma and
ducts (Fig. 1a). The level of accumulated saline is modulated by an
assistant utilizing a suction catheter in order to prevent pooling.
Excessive suctioning is avoided because a sufficient amount of
saline must remain to couple the electrode and tissue at all times.
Finally, the transected stump is carefully inspected and further
treatment is applied to any areas of concern for incomplete sealing
(Fig. 1b).
Patients were excluded from the study if they had been lost to
clinical follow-up. The primary outcome measure was the occur-
rence of any significant procedure-related complication, including
POPF or the need for repeat intervention. Secondary outcome
measures were length of initial hospitalization, need for
re-admission, and duration of operatively placed drains. Postop-
erative pancreatic fistula was defined in accordance with the defi-
nition of the ISGPF.18 Abdominal computerized tomography (CT)
imaging was obtained during follow-up.
(a)
(b)
Figure 1 (a) The hook device (EndoSH 2.0™; Salient Surgical Tech-
nologies, Inc.) is used to separate and lift the pancreatic parenchyma
to facilitate division during distal pancreatectomy utilizing saline-
coupled radiofrequency ablation (RFA). Continuous RFA energy is
delivered to allow consistent dissection and concomitant sealing of
the pancreatic parenchyma. (b) After complete transection of the
pancreatic body, the remnant is inspected and treated to ensure
complete sealing
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Results
Thirty-four patients met the study inclusion criteria; clinical
factors are listed in Table 1 and final pathological diagnoses are
listed in Table 2. One patient was lost to follow-up and was there-
fore excluded. Three patients (9.1%) were diagnosed with POPF.
Of these, two patients (6.1%) demonstrated a POPF necessitating
a prolonged duration of the operative drain (grade A), and one
patient (3.0%) required endoscopic cystogastrostomy for resolu-
tion (grade C). The latter patient represented the only procedure-
related re-admission. The only other significant complication
(3.0%) was a perforated gastric ulcer that required partial gastrec-
tomy. This patient had undergone an uneventful initial DP, but
had failed to tolerate advancement to a diet postoperatively. This
patient developed haematemesis on postoperative day 3 and
diagnostic investigation of the upper gastrointestinal (GI) tract
revealed a leak at the distal stomach. Emergent laparotomy was
performed, in which a perforation of the distal great curvature
was noted. Distal gastrectomy and Billroth II reconstruction were
performed without further complication. The patient’s diet was
slowly advanced in preparation for discharge. The aetiology of the
perforated gastric ulcer was unclear, but the most probable expla-
nation was pre-existing patient disease. Although unlikely, local
thermal injury during the DP cannot be excluded.
Abdominal CT scans were obtained in 29 (87.9%) patients at an
average of 8 months (range: 3–22.5 months) postoperatively. A
subset of 16 of the 29 (55.2%) patients with no clinically signifi-
cant POPF demonstrated a peripancreatic fluid collection. These
collections varied from <1 cm to 4 cm in maximum diameter.
None of the collections demonstrated any concerning features
indicating local tumour recurrence or severe POPF. Repeat CT
scanning demonstrated a reduction in size or the complete reso-
lution of most collections without operative intervention.
Discussion
The present study reports an overall rate of POPF of 9.1% and a
3.0% rate of clinically significant POPF after laparoscopic, hand-
assisted DP utilizing saline-coupled RFA. Although direct com-
parison was not possible because of low sample numbers and
variations in techniques used in the historical group, this repre-
sents an improvement from rates of 22.2% and 11.1% for overall
incidence and occurrence of clinically significant POPF, respec-
tively, prior to the adoption of saline-coupled RFA. Overall inci-
dences of POPF reported in the literature vary from 5% to 33%,1–5
and frequencies of clinically significant fistula range from 9% to
16%.1,3–7 A recent study of the use of saline-coupled RFA for DP
cited similar results, reporting a POPF diagnosed in three of 29
patients (10.3%), two cases of which were clinically significant
(grade B: 6.9%).19
Saline-coupled RFA has many inherent properties that may
account for an improved sealing effect. The constant presence of
saline allows the efficient conduction of thermal energy to a rela-
tively wider area than that afforded by RFA cautery alone. The
fluid is constantly replaced, which allows for cooling and consis-
tent collagen denaturation in the absence of local tissue charring.17
The reduction in tissue damage is important in pancreatic proce-
dures for malignancy because it allows as much histological speci-
men as possible to be preserved for analysis. Early evidence has
demonstrated that saline-coupled RFA improves haemostasis
compared with other devices during hepatic resection.20 Although
bleeding is not usually as critical as in the setting of pancreatic
resection, this effect underscores a sealing facility that may explain
the reduction in pancreatic duct leaks and subsequent POPF.
Although DP is traditionally performed using laparotomy,
current practice shows a trend towards the use of minimally inva-
sive approaches. Laparoscopic surgery, hand-assisted laparoscopic
surgery (HALS) and robot-assisted procedures have all been
reported.Minimally invasive DP is purported to confer the advan-
tages of a reduced complication rate and shorter postoperative
length of stay.21 In the present study, HALS was utilized for all
procedures. Oddly, an increased incidence of POPF has consis-
tently been reported with the use of laparoscopy, with frequencies
ranging from 13% to 50% in early reports.1,4,21 The reasons for this
discrepancy are uncertain, but a learning curve may exist as a
result of the recent adoption of laparoscopy for DP. Another
reason may be that tactile feedback can be gleaned in HALS or
open procedures, which allows the operating surgeon to discrimi-
nate the varying texture of the pancreatic parenchyma. A firm,
fibrotic pancreas is more likely to seal well than a more normal
pancreas and is thus able to be treated accordingly. Interestingly,
saline-coupled RFA provides a clear advantage irrespective of any
Table 1 Clinical and operative characteristics (n = 33 patients)
Patient age, mean (range) 60 (14–79)
Male gender, n (%) 10 (30.3)
Body mass index, kg/m2, mean (range) 28.3 (16–46)
Other concomitant procedure, n (%) 6 (18.2)
Spleen-preserving distal pancreatectomy, n (%) 4 (12.1)
Duration of initial drain, days, mean (range) 9.4 (5–67)
Length of stay, days, mean (range) 5.82 (3–23)
Table 2 Final pathology (n = 33 patients)
Pathology Patients, n (%)
Mucinous cystic neoplasm 11 (33.3)
Neuroendocrine tumour 8 (24.2)
Intraductal papillary mucinous neoplasm 3 (9.1)
Serous cystadenoma 3 (9.1)
Other benign cyst 3 (9.1)
Pseudocyst 2 (6.1)
Accessory spleen 2 (6.1)
Trauma 1 (3.0)
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tactile feedback because it performs similarly irrespective of the
composition of the tissue being treated.
Another advantage of the RFA method refers to the fact that it
performs consistently, irrespective of the thickness of the pan-
creatic parenchyma. Currently, a commonly utilized technique
for DP involves a stapled transection of the pancreatic paren-
chyma. Although this technique is effective and facile in the vast
majority of circumstances, stapled transection of a thick or cal-
cified pancreatic body can pose a formidable challenge. Potential
problems range from a simple requirement for increased effort
to manipulate the stapler, to the need to crush the pancreas with
another instrument prior to stapling, and to incomplete transec-
tion with compromise of the staple line. Traditional stapling
devices can accommodate tissue thicknesses of up to 2 mm and
the recently developed Endo-GIA™ Black Cartridge (Covidien,
Inc., Mansfield, MA, USA) has a capacity of 3 mm. However, this
may not provide sufficient depth for some thickened pancreatic
bodies, which are reported to be up to 9 mm thick.7 Using a
stapling device for tissue that exceeds the recommended thick-
ness can result in stapler dysfunction, need for multiple staple
applications, or poor tissue approximation, all of which can con-
tribute to improper parenchymal transection and potential
POPF. Given time, saline-coupled RFA can facilitate the division
of tissue of any thickness. The saline allows for both the regular
transfer of thermal energy through the tissue, as well as for local
cooling as the saline disperses. Although cautery can accommo-
date any tissue thickness, it subjects tissue to potential poor
conduction alternating with increased focal temperatures and
local charring.
Other than POPF, one other significant complication, a possible
local thermal injury of the stomach, occurred in the present series.
Although thermal spread is a theoretical possibility in saline-
coupled RFA, the saline should help to diffuse thermal energy if
used properly. However, care should be taken to prevent the exces-
sive pooling of heated saline during intense or prolonged use.
Although the device requires an appropriate amount of saline to
maintain tissue contact, judicious suctioning of accumulated
saline minimizes the chance of local thermal spread. There are no
other reports of occurrences of gastric or other viscous perfora-
tion as a complication of the device. This event reinforces the fact
that care must be taken with any energy device.
The asymptomatic peripancreatic fluid collections noted
during follow-up merit further discussion. Clinically silent collec-
tions were noted following 16 (55.2%) of the procedures for
which follow-up CT was obtained (Fig. 2a, b). In the setting of
pancreatic resection, such a collection may represent an anasto-
motic failure, POPF or an RFA-related artefact. Screening CT in
asymptomatic patients, although rarely performed in other series,
has noted collections in a significant majority of patients.11 In
the present series, sampled collections were found to consist of
necrotic debris and appeared to correlate to the defects seen after
the use of RFA in the liver. All collections in this series remained
asymptomatic during the follow-up period without intervention,
and many of these collections exhibited reduced size or were
found to have resolved in repeat CT.
One asymptomatic patient underwent endoscopic aspiration of
this collection 4 months postoperatively over concern about an
elevated serum chromogranin A level. Analysis of the aspirate
revealed typical necrotic debris. However, the patient subse-
quently developed a fever and leukocytosis consistent with an
abscess, necessitating endoscopic cystogastrostomy. Although a
significant number of patients in this series exhibited these peri-
pancreatic collections, none were associated with a local recur-
rence. Furthermore, none exhibited features such as an increase in
size or vascular ingrowth on arterial-phase CT that might raise
concern about potential tumour recurrence.22 These findings
(a)
(b)
Figure 2 Computerized tomography following distal pancreatec-
tomy utilizing saline-coupled radiofrequency ablation (RFA). (a) A
hypoattenuated area (arrow) is present along the medial pancreatic
body approximately 2 cm proximal to the resection line, retaining the
shape of the original pancreas. This collection has remained clini-
cally silent and may represent cystic degeneration following RFA. (b)
A cystic area (arrow) is apparent outside the border of the original
pancreas. This region may represent a pseudocyst or contained
pancreatic fistula. This collection has also remained clinically silent
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demonstrate that further investigation of the use of saline-
coupled RFA in DP is required in order to clearly define indica-
tions for sampling of any procedure-associated fluid collection.
The strengths of this study include its consistent application of
the RFA device using a standardized procedure developed and
implemented by the same surgeon (LWT) in each case. Significant
variation is often reported in studies focused on DP, possibly as a
result of the myriad of accepted techniques for both parenchymal
division and remnant closure.
The weaknesses of the study include its retrospective, case series
design. Larger prospective series comparing the most common
techniques are needed. In the diagnosis of POPF, amylase levels
were not assessed to determine the true incidence of clinically
silent, grade A fistulas. The study reports the incidence of clinically
significant POPF, as well as POPF identified by CT scan during
routine follow-up.
Conclusions
The present study reports a 9.1% incidence of POPF in DP
utilizing saline-coupled RFA for the division and closure of the
pancreatic remnant and notes that only one (3.0%) patient
experienced clinically significant POPF requiring repeat interven-
tion. The present rate of overall significant complications of 6.1%
is comparable with rates in previous reports. The use of saline-
coupled RFA alone for pancreatic parenchymal division and
remnant closure after DP is safe and effective.
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